|
|
|
|
|
|
|
|
|
 |
|
|
© Newswise.
|
|
Tipsheet from ASCPT March Meeting
Newswise — The ASCPT annual meeting, being held from March 2 to 5 at the Walt Disney World Swan and Dolphin Hotel in Orlando, includes 400 scientific sessions that cover the spectrum of issues in drug discovery, development, regulation and usage. Presentations will integrate the changes that are emerging in the area of personalized drug therapy as a result of decoding the human genome. Sessions covering medical topics include: · A new use for an existing drug to decrease the inflammation recently associated with heart attacks and some types of strokes. · New findings about Goldenseal inhibiting the body’s enzyme activity to the extent that its effect on other drugs might be toxic. · A new use for an existing drug to treat malaria more effectively than current drugs. Sessions on supplements and foods will address: · That people with type 2 diabetes should not take St. John’s Wort if they use the common diabetes drug rosiglitazone. · Parkinson’s patients finding it useful to drink grapefruit juice if they are taking the drug Cabergoline. · A Korean study connecting the eating of hot peppers and other spicy foods with the tendency to smoke. Sessions on science policy and public policy issues are: Corporate Influence in Research is the title of a workshop featuring Alastair J. Wood, Vanderbilt University School of Medicine, speaking on How Do Medical Journals Cope with Corporate Influence in Research. The meeting features a panel of distinguished experts debating the proposition: The Medicare Prescription Drug Benefit Is Good for America’s Seniors. See the complete ASCPT meeting program at http://www.ascpt.org. MEDIA INFORMATION Newsroom, March 2 – 5, Swan and Dolphin Hotel, Europe 8 -- 407.934.4316. Fax 407.934.4315 Hotel Accommodations
|
|
||||||||||||||||||
